We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong value characteristics for investors to consider today, January 30th:
Banco Macro S.A. (BMA - Free Report) : This company that provides various banking products and services to individuals and corporate customers has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 28.8% over the last 60 days.
American Equity Investment Life Holding Company : This provider of life insurance products and services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 39.1% over the last 60 days.
American Equity Investment Life Holding Company Price and Consensus
H&R Block, Inc. (HRB - Free Report) : This provider of assisted income tax return preparation services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 21.9% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Value Stocks to Buy for January 30th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, January 30th:
Banco Macro S.A. (BMA - Free Report) : This company that provides various banking products and services to individuals and corporate customers has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 28.8% over the last 60 days.
Macro Bank Inc. Price and Consensus
Macro Bank Inc. price-consensus-chart | Macro Bank Inc. Quote
Banco Macro has a price-to-earnings ratio (P/E) of 3.11 compared with 5.20 for the industry. The company possesses a Value Score of A.
Macro Bank Inc. PE Ratio (TTM)
Macro Bank Inc. pe-ratio-ttm | Macro Bank Inc. Quote
American Equity Investment Life Holding Company : This provider of life insurance products and services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 39.1% over the last 60 days.
American Equity Investment Life Holding Company Price and Consensus
American Equity Investment Life Holding Company price-consensus-chart | American Equity Investment Life Holding Company Quote
American Equity Investment has a price-to-earnings ratio (P/E) of 6.54 compared with 12.90 for the industry. The company possesses a Value Score of A.
American Equity Investment Life Holding Company PE Ratio (TTM)
American Equity Investment Life Holding Company pe-ratio-ttm | American Equity Investment Life Holding Company Quote
H&R Block, Inc. (HRB - Free Report) : This provider of assisted income tax return preparation services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 21.9% over the last 60 days.
H&R Block, Inc. Price and Consensus
H&R Block, Inc. price-consensus-chart | H&R Block, Inc. Quote
H&R Block has a price-to-earnings ratio (P/E) of 9.68 compared with 29.30 for the industry. The company possesses a Value Score of A.
H&R Block, Inc. PE Ratio (TTM)
H&R Block, Inc. pe-ratio-ttm | H&R Block, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
Find more top income stocks with some of our great premium screens.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>